Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2019 09:27 ET | Source: Resverlogix Corp

Resverlogix Announces US$12 Million Debenture Financing and Full Repayment of Loan

CALGARY, Alberta, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has issued a 10% secured convertible debenture in the...
September 26, 2019 19:04 ET | Source: Resverlogix Corp

Resverlogix to Host BETonMACE Webcast and Conference Call

CALGARY, Alberta, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that, in connection with BETonMACE topline results, expected to be...
September 23, 2019 08:30 ET | Source: Resverlogix Corp

Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019

CALGARY, Alberta, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announced today the Late Breaking Science submission, regarding the primary results...
August 14, 2019 08:30 ET | Source: Resverlogix Corp

Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019

CALGARY, Alberta, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announces today that it will present at ESC Congress 2019, held this year in Paris,...
July 15, 2019 08:30 ET | Source: Resverlogix Corp

Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics

CALGARY, Alberta, July 15, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: “Apabetalone (RVX-208)...
July 08, 2019 08:30 ET | Source: Resverlogix Corp

Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits

CALGARY, Alberta, July 08, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) is pleased to announce today that all patients active in BETonMACE, the Company’s...